Once we jump this phase 2 hurdle, and get orphan drug designation apporval by FDA, and the SP is still in the dumps, thered be a consolidation.
Anyone going to watch the webinar tomorrow ?
- Forums
- ASX - By Stock
- ATH
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
ATH
alterity therapeutics limited
Add to My Watchlist
9.09%
!
1.0¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-69
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $91.27M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $9.899K | 912.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 14913296 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 15978660 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 14913296 | 0.010 |
28 | 26405228 | 0.009 |
16 | 28051963 | 0.008 |
13 | 4068106 | 0.007 |
15 | 9628518 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 15978660 | 13 |
0.012 | 38626691 | 32 |
0.013 | 8121214 | 17 |
0.014 | 12798180 | 7 |
0.015 | 2059976 | 9 |
Last trade - 14.32pm 18/06/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online